Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FVKNT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,780
Award facts
- Contract value 100% obligated
- $49,780.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injections with a ceiling value of $49,780.26. This firm fixed-price delivery order, awarded on September 8, 2025, with an ultimate completion date of September 9, 2025, will be performed at the awardee's corporate headquarters in Conshohocken, Pennsylvania. No set-aside designation was used in this competitive award. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 million global pharmaceutical support vehicle extending through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement needs through its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies. As a prime contractor under the DLA's Pharmaceutical Prime Vendor Global Program, the company supplies healthcare commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Dupixent supply under this delivery order supports the military healthcare system's pharmaceutical procurement requirements through the established IDC vehicle.
Quick answers
Who was awarded contract SPE2DB25FVKNT?
SPE2DB25FVKNT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 8, 2025.
How much is contract SPE2DB25FVKNT worth?
The government has obligated $49,780 on SPE2DB25FVKNT.
Is contract SPE2DB25FVKNT an order under another contract?
Yes. SPE2DB25FVKNT is a delivery order under SPE2DB25D3017, an indefinite delivery contract.
Was contract SPE2DB25FVKNT competed?
The extent of competition for SPE2DB25FVKNT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award